Skip to content

MOLN

Molecular Partners AG

NASDAQ · Healthcare · Biotechnology · CH

$3.20
+3.40%
Ask drillr
Institutional positioning

13F filings over the trailing two quarters

New 2Increased 0Reduced 1Sold out 0
FilerActionSharesFiled
SUVRETTA CAPITAL MANAGEMENT, LLCUnchanged2,221,494May 15, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCUnchanged2,221,494Aug 14, 2026
BVF INC/ILUnchanged1,353,968Aug 14, 2026
BVF INC/ILUnchanged1,353,968May 15, 2026
CITADEL ADVISORS LLCNew Position17,179Sep 2, 2026
MORGAN STANLEYReduced367May 15, 2026
MORGAN STANLEYUnchanged367Aug 13, 2026
UBS Group AGNew Position279Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings